Engineered Antibodies Pry Apart The Most Difficult Viruses

New structural insights reveal a clever new use of antibodies to treat and possibly prevent infections by on the of the world ...
EurekAlert!

Discovery of rapid COVID-19 replication mechanism and expanded treatment options

A schematic diagram showing the significant contribution of SCoV2-induced altered mitochondrial dynamics and mitochondrial EGFR translocation in sustaining viral propagation. First, SCOV2 RNA and ...
Baylor College of Medicine

Some human GII.4 norovirus are better than others at infecting cells

Human noroviruses, GII.4 strains in particular, are the chief drivers of acute viral gastroenteritis around the world, a condition for which there are no vaccines or antivirals. Understanding how ...
Forbes

New Antibody Treatment Could Help Prevent HIV Infection

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Example antibody-drug conjugate A recent experimental treatment may offer a new method to ...
USA Today

Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19

BOSTON, MA / ACCESS Newswire / March 2, 2026 / Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company developing carbohydrate-based therapeutics, today announced results from a ...
Techno-Science.net on MSN

⚕️ When a virus carries another: the "Trojan horse" of deltaviruses

Some tiny viruses, called deltaviruses, can only spread by relying on other viruses. A study published in Cell shows that ...
EurekAlert!

Some human GII.4 norovirus are better than others at infecting cells; researchers have found an explanation

Human noroviruses, GII.4 strains in particular, are the chief drivers of acute viral gastroenteritis around the world, a condition for which there are no vaccines or antivirals. Understanding how ...